Imalytics

About Imalytics

Imalytics operates in the Software & AI space and is among the firms Bracken expects to track at SNMMI 2026.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Nuclear Medicine Today · 2026-07-14
  Imalytics files IND for next-generation PSMA-targeted agent
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• PR Newswire · 2026-04-21
  Imalytics partners with academic center on Actinium-225 program
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Imaging Wire · 2026-01-12
  Imalytics closes Series C round to scale radiopharma manufacturing
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.